immunotherapy

You have access
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang

Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
You have access
Immunology and immunotherapy in breast cancer
Vladimir Semiglazov, Andrey Tseluiko, Asel Kudaybergenova, Anna Artemyeva, Petr Krivorotko and Roman Donskih

Cancer Biology & Medicine May 2022, 19 (5) 609-618; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0597
You have access
The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
Kaiting Wang, Xinyao Qiu, Yan Zhao, Hongyang Wang and Lei Chen

Cancer Biology & Medicine March 2022, 19 (3) 305-318; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0306
You have access
Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye

Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
You have access
Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun

Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
You have access
Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren

Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029
You have access
Targeting myeloid-derived suppressor cells for cancer therapy
Hongchao Tang, Hao Li and Zhijun Sun

Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806
You have access
Updating targets for natural killer/T-cell lymphoma immunotherapy
Weili Xue and Mingzhi Zhang

Cancer Biology & Medicine February 2021, 18 (1) 52-62; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0400
You have access
The role and its mechanism of intermittent fasting in tumors: friend or foe?
Xu Zhao, Jing Yang, Ruoyu Huang, Mengmeng Guo, Ya Zhou and Lin Xu

Cancer Biology & Medicine February 2021, 18 (1) 63-73; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0250
You have access
The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer
Yue Fan, Haifeng Ying, Xueying Wu, Huan Chen, Ying Hu, Henghui Zhang, Lijia Wu, Ying Yang, Beibei Mao and Lan Zheng

Cancer Biology & Medicine November 2020, 17 (4) 1002-1013; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0089

Main menu

User menu

Search

immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services